The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 24, 2026

Filed:

Sep. 16, 2022
Applicant:

Parata Systems, Llc, Durham, NC (US);

Inventors:

Russell F. Lewis, Dallas, TX (US);

Arthur F. Swanson, Cary, NC (US);

Todd Martin Jenkins, Raleigh, NC (US);

Assignee:

PARATA SYSTEMS, LLC, Durham, NC (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G06T 7/00 (2017.01); G06T 11/00 (2006.01); G06V 10/776 (2022.01); G16H 20/10 (2018.01); G16H 50/30 (2018.01);
U.S. Cl.
CPC ...
G06T 7/0004 (2013.01); G06T 11/00 (2013.01); G06V 10/776 (2022.01); G16H 20/10 (2018.01); G16H 50/30 (2018.01); G06T 2207/30108 (2013.01);
Abstract

A method includes receiving a drug product package containing one or more drug products therein; evaluating the one or more drug products contained in the drug product package based on a plurality of drug product evaluation factors, the plurality of drug product evaluation factors including an enhanced scrutiny factor; assigning a validation score to the drug product package based on evaluating the one or more drug products contained in the drug product package, a magnitude of the validation score being greater with decreasing patient risk; and validating the drug product package. Validating the drug product package comprises: validating the drug product package based on a first comparison of the magnitude of the validation score with a first threshold responsive to a presence of the enhanced scrutiny factor and a second comparison of the magnitude of the validation score with a second threshold responsive to an absence of the enhanced scrutiny factor, the first threshold being greater than the second threshold; or identifying the drug product package as requiring manual validation responsive to the presence of the enhanced scrutiny factor.


Find Patent Forward Citations

Lewis, Russell. (2026). Methods, systems, and computer program product for validating drug product package content using tiered evaluation factors (U.S. Patent No. 12561781). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12561781

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…